Clinical Study Results
Research Sponsor: AstraZeneca AB
Drug Studied: AZD8154
Study Title: A study to learn about the safety of different doses and
forms of AZD8154 in healthy participants
Thank you!
Thank you to the participants who took part in the clinical study for the study drug
AZD8154. AstraZeneca AB sponsored this study and thinks it is important to share
the results. An independent non-profit organization called CISCRP helped prepare
this summary of the study results.
If you participated in the study and have questions about the results, please speak
with the doctor or staff at your study site.
What is happening with the study now?
The study started in July 2018 and ended in July 2019. It included 78 participants
in Germany.
The study had 3 parts:
• Part A included 48 participants
• Part B included 6 participants
• Part C included 24 participants
The sponsor reviewed the data collected when the study ended and created a
report of the results. This is a summary of that report.
1